Noun
alemtuzumab (uncountable)
(pharmacology) A monoclonal antibody used in the treatment of chronic lymphocytic leukemia and T-cell lymphoma, targeting CD52.
Alemtuzumab (Campath), a monoclonal antibody that attacks white blood cells, has been used in treatment with greater success than previous options. Source: Internet